End-of-life choices for advanced cancer aided by intervention

This article originally appeared here.
Intervention Assists End-of-Life Decisions in Advanced Cancer
Intervention Assists End-of-Life Decisions in Advanced Cancer

(HealthDay News) -- In advanced cancer patients, an intervention with a pamphlet and discussion to assist with end-of-life decision making is associated with earlier placement of do-not-resuscitate (DNR) orders and less likelihood of death in the hospital, according to research published online July 29 in the Journal of Clinical Oncology.

Rhea A. Stein, Ph.D., of the University of Sydney, and colleagues conducted a randomized controlled trial to determine the efficacy of a structured intervention to assist advanced cancer patients with making end-of-life decisions. Patients with metastatic cancer who were no longer receiving curative treatment were randomly assigned to intervention with an informational pamphlet and discussion (55 patients) or usual treatment (65 patients).

The researchers found comparably high rates of DNR orders in both groups. According to per-protocol analyses, patients receiving the intervention placed DNR orders earlier (median number of days before death, 27 versus 12.5 days) and were more likely to avoid death in the hospital (19 versus 50 percent) than patients receiving treatment as usual. There was no evidence that the intervention caused anxiety or depression.

"An intervention, consisting of an informational pamphlet and discussion, was associated with earlier placement of DNR orders relative to death and less likelihood of death in hospital," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs